Am J Psychiatry

1. KU SH, Stringfield SJ, Torregrossa MM, Sweet RA, et al
   Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia.
   Am J Psychiatry. 2026 Apr 17:appiajp20250886. doi: 10.1176/appi.ajp.20250886.
   

   >> Share

   
   

   
   Br J Psychiatry

2. SMITH A, Griffin NP, Grana J, Buadze A, et al
   'Where you swim, she drowns': schizophrenia and Finnegans Wake (1939) - Psychiatry in literature.
   Br J Psychiatry. 2026;228:495-496.
   

   >> Share

   
   
3. DE LA HOZ JF, Arias A, Service SK, Castano M, et al
   Characterisation of serious mental illness trajectories through transdiagnostic clinical features.
   Br J Psychiatry. 2026;228:446-453.
   

   >> Share

   
   

   
   J Clin Psychiatry

4. UMBRICHT D, Abt M, Derks M, Hernandez MC, et al
   A Phase 2b Multicenter Study to Evaluate Basmisanil as an Adjunctive Treatment in Patients With Cognitive Impairment Associated With Schizophrenia.
   J Clin Psychiatry. 2026;87:25m16022.
   

   >> Share

   
   

   
   Mol Psychiatry

5. CUI L, Kurganov E, Hawes D, Hornauer P, et al
   Loss of schizophrenia risk gene XPO7 disrupts neuronal excitability and network regularity via altered Na(+) channel dynamics in human neurons.
   Mol Psychiatry. 2026 Apr 15. doi: 10.1038/s41380-026-03587.
   

   >> Share

   
   
6. CHENG M, Yin Y, Engchuan W, Heung T, et al
   Genome-wide tandem repeat expansions modify schizophrenia risk in the presence of a 22q11.2 deletion.
   Mol Psychiatry. 2026 Apr 15. doi: 10.1038/s41380-026-03574.
   

   >> Share

   
   
7. MCKENNA F, Vinke LN, Williams M, Gaw M, et al
   Postpartum psychosis is associated with elevated neuromelanin-MRI signal in the midbrain.
   Mol Psychiatry. 2026 Apr 15. doi: 10.1038/s41380-026-03476.
   

   >> Share

   
   
8. FENNER E, Holmans P, O'Donovan MC, Owen MJ, et al
   Analysis of rare coding variants in schizophrenia-associated genes and generalised cognition in the UK Biobank.
   Mol Psychiatry. 2026 Apr 10. doi: 10.1038/s41380-026-03601.
   

   >> Share

   
   

   
   Nat Genet

9. WU Y, Zheng Z, Thibaut L, Lin T, et al
   Genome-wide fine-mapping improves identification of causal variants.
   Nat Genet. 2026;58:940-951.
   

   >> Share

   
   

   
   Neuropsychopharmacology

10. HORNG JE, McCrea LT, Batorsky RE, Bowen JJ, et al
    Functional genomic profiling of schizophrenia-associated genes reveals key microglial regulators.
    Neuropsychopharmacology. 2026 Apr 16. doi: 10.1038/s41386-026-02406.
    

    >> Share

    
    
11. YANG BZ, He L, Liu TQ, Ma S, et al
    Causal links among gut microbiota, immune-inflammatory and compensatory immune-regulatory systems, and schizophrenia.
    Neuropsychopharmacology. 2026 Apr 15. doi: 10.1038/s41386-026-02407.
    

    >> Share

    
    

    
    PLoS One

12. BAMPOS C, Megalooikonomou V
    Exploration of schizophrenia-associated gene modules using graph theory, co-expression networks, and dimensionality reduction.
    PLoS One. 2026;21:e0346663.
    

    >> Share

    
    
13. BARBALAT G, Plasse J, Chereau-Boudet I, Gouache B, et al
    Are routinely collected clinical and sociodemographic characteristics associated with social functioning and activities of daily living in schizophrenia? A machine learning approach descriptive of a schizophrenia cohort.
    PLoS One. 2026;21:e0347326.
    

    >> Share

    
    

    
    Psychiatry Res

14. DUDAKLI BB, Uzel HK, Ocak MS, Esen Oksuzoglu M, et al
    Changes in serum Nogo-A and BDNF levels following treatment in drug-naive first-episode schizophrenia: A naturalistic prospective study.
    Psychiatry Res. 2026;361:117149.
    

    >> Share

    
    

    
    Schizophr Res

15. MILLER CR, Taylor SF, Breier A, Vohs JL, et al
    Factor analysis of two COMPASS psychopathology symptom scales for first-episode psychosis.
    Schizophr Res. 2026;294:1-6.
    

    >> Share

    
    
16. GAGO E, Montalvo I, Cabezas A, Ortega L, et al
    Perinatal stress as a moderator of the effects of hormonal dysregulation on cognition and symptoms in early psychosis.
    Schizophr Res. 2026;293:147-155.
    

    >> Share

    
    
17. NAGENDRA A, Mesholam-Gately RI, Shafrin J, Keshavan MS, et al
    Corrigendum to "Reframing schizophrenia as a neurodevelopmental syndrome: The scientific and social imperative" [Schizophr. Res. Volume 292, June 2026, pages 96-102].
    Schizophr Res. 2026 Apr 15:S0920-9964(26)00117.
    

    >> Share

    
    
18. COHEN I, Bukowski E
    Predictors of antidepressant prescribing in schizophrenia: A retrospective analysis.
    Schizophr Res. 2026;293:144-146.
    

    >> Share

    
    
19. GARCIA-SAN NICOLAS C, Diaz-Pons A, Paras C, Ortiz-Garcia de la Foz V, et al
    Exposome and cognition in psychosis: an exploratory study in sex-specific patterns in patients and their unaffected siblings.
    Schizophr Res. 2026;293:134-143.
    

    >> Share

    
    
20. PASCOE B, Cocks K, Clarke N, Langevin N, et al
    Structural and construct validity assessment of the schizophrenia cognition rating scale (SCoRS) using data from three international phase 3 randomized controlled trials (CONNEX programme).
    Schizophr Res. 2026;293:124-133.
    

    >> Share

    
    
21. WU CJ, Lin JJ, Huang CC, Tseng HH, et al
    Development and evaluation of a predictive biomarker model based on the niacin flush pathway for differentiating schizophrenia and bipolar disorder.
    Schizophr Res. 2026;293:113-123.
    

    >> Share

    
    
22. WERST MJA, Tiraboschi GA, Paquin V
    Digital cultures and the exposome of psychosis.
    Schizophr Res. 2026;293:109-112.
    

    >> Share

    
    
23. KAMP D, Riesbeck M, Lowe A, Weide K, et al
    Predictors of gains in social functioning after cognitive remediation in schizophrenia: Results from the multicenter ISST (Integrated Social Cognition and Social Skills Therapy) trial.
    Schizophr Res. 2026;293:99-108.
    

    >> Share

    
    
24. HAMZAI HV, D'Arcey J, Jagtap S, Leibovitz T, et al
    The role of cognitive schemas in personal recovery, symptom severity, and functioning in schizophrenia-spectrum disorders.
    Schizophr Res. 2026;293:91-98.
    

    >> Share

    
    
25. SHIVAKUMAR G, Szymaniak K, Bell E, Malhi GS, et al
    Schizoaffective disorder - A conglomerated disorder that needs an amalgamation of ideas.
    Schizophr Res. 2026;292:60-68.
    

    >> Share

    
    
26. DALLOUL N, Kandala S, Moran E, Barch DM, et al
    Negative symptoms and resting state functional connectivity: Leveraging ecological momentary assessment and individual-specific techniques.
    Schizophr Res. 2026;292:28-40.
    

    >> Share

    
    
27. RICHARDS SE, Davis A, Blake C, Errington H, et al
    Challenges and priorities in researching and managing altered perceptual experiences: Shared academic and lived experience perspectives.
    Schizophr Res. 2026;292:12-20.
    

    >> Share

    
    
28. PILLNY M, Edwards CJ, Riehle M
    Beyond the emotion paradox: Avenues to understanding anhedonia in schizophrenia.
    Schizophr Res. 2026;294:17-26.
    

    >> Share

    
    
29. PRETTYMAN GE, Kales E, Didier P, Savage C, et al
    Impaired intrinsic motivation in psychosis risk relates to ventral striatum activation to self-generated reinforcement signals.
    Schizophr Res. 2026;294:7-16.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share